发明公开
- 专利标题： COMPOUNDS AND METHODS OF USE
- 专利标题（中）： 化合物及其使用方法
-
申请号： EP05722533.6申请日： 2005-01-24
-
公开(公告)号： EP1713484A2公开(公告)日： 2006-10-25
- 发明人: POTASHMAN, Michele , KIM, Tae-seong , BELLON, Steven , BOOKER, Shon , CHENG, Yuan , KIM, Joseph, L. , TASKER, Andrew , XI, Ning , XU, Shimin , HARMANGE, Jean-Christophe , BORG, George , WEISS, Matthew , HODOUS, Brian, L. , GRACEFFA, Russell , BUCKNER, Willianm, H. , MASSE, Craig, E. , CHOQUETTE, Deborah , MARTIN, Matthew, W. , GERMAIN, Julie , CHAFFEE, Stuart, C. , NUNES, Joseph, J. , PATEL, Vinod, F. , BUCHANAN, John L. , DIPIETRO, Lucian V. , HABGOOD; Gregory J. , McGOWAN; David C. , WHITTINGTON, Douglas A. , LA, Daniel
- 申请人： AMGEN INC.
- 申请人地址： M/S 27-4-A, Amgen Inc., One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 专利权人： AMGEN INC.
- 当前专利权人： AMGEN INC.
- 当前专利权人地址： M/S 27-4-A, Amgen Inc., One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 代理机构： Jacob, Reuben Ellis
- 优先权： US538691P 20040123
- 国际公布： WO2005070891 20050804
- 主分类号： A61K31/505
- IPC分类号： A61K31/505
摘要：
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
信息查询
